ArticleProceedings of the National Academy of Sciences of the United States of America2020

Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.

Faye-Marie Vassel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.